Skip to main content
MedinCell successfully renegotiates the drawdown conditions of the last tranche of the EIB loan and secures an additional €5m of non-dilutive funding
June 10, 2020
MedinCell announces fiscal year consolidated results April 2019 – March 2020
June 4, 2020
Videoconference and publication of the results for the 2019-2020 financial year, on June 4, 2020
May 25, 2020
Adapt and overcome in response to the Covid-19 crisis
April 23, 2020
MedinCell launches Regulatory Development of mdc-WWM Program
April 22, 2020
Invitation to a webcast: adapting and acting in response to the Covid-19 crisis
April 20, 2020
MedinCell has launched a COVID-19 research initiative based on its experience to formulate long-acting injectable Ivermectin
April 6, 2020
MedinCell receives $ 6.4 million grant from Unitaid to fight Malaria
March 25, 2020
US Pharma Development Veteran Dr. Richard Malamut Joins the Medical Advisory Board of MedinCell
January 28, 2020
MedinCell provides a portfolio update for J.P. Morgan Healthcare Conference 2020
January 13, 2020
